Main > INFECTIOUS DISEASES > USA. G. HCV Infection>Treat. S+V+V>

---

USA. G. HCV Infection>Treat. S+V+V>'s subsections
(*) CN Approval Date: 2019. 12.20
(*) EU CE Mark Date: 2017. 07.28
(*) USA Approval Date: 2017. 07.18.
>NS5B Inh.+Velpatasvir+Voxilaprevir
Company
Generic Name: Sofosbuvir
NS: Non-Structural
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 12.28
RTM
RTM Web-Site

USA. G. HCV Infection>Treat. S+V+V>'s products
This section has no products